Enlai Dai

Lanzhou, 730000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Icariin sensitizes glucocorticoid therapy in doxorubicin-induced fibrotic nephrotic syndrome via the HIF-1α/NF-κB/HDAC2 Axis.

Icariin sensitizes glucocorticoid therapy in doxorubicin-induced fibrotic nephrotic syndrome via the HIF-1α/NF-κB/HDAC2 Axis.

Journal: International immunopharmacology

Published: September 12, 2025

Characterization and Clinical Diagnostic Potential of IHRDEGs in Renal Interstitial Fibrosis: An Integrative Data Analysis and Model Construction Study.

Characterization and Clinical Diagnostic Potential of IHRDEGs in Renal Interstitial Fibrosis: An Integrative Data Analysis and Model Construction Study.

Journal: Journal of inflammation research

Published: July 18, 2025

Icariin ameliorates minimal change disease by regulating the mitochondrial dysfunction pathway: an integrated strategy of network pharmacology, bioinformatics, and experimental validation.

Icariin ameliorates minimal change disease by regulating the mitochondrial dysfunction pathway: an integrated strategy of network pharmacology, bioinformatics, and experimental validation.

Journal: Frontiers in pharmacology

Published: June 04, 2025

Association between hypothyroidism and nephrotic syndrome: a bidirectional two-sample Mendelian randomization analysis.

Association between hypothyroidism and nephrotic syndrome: a bidirectional two-sample Mendelian randomization analysis.

Journal: Renal failure

Published: August 15, 2024

Advances in the study of key cells and signaling pathways in renal fibrosis and the interventional role of Chinese medicines.

Advances in the study of key cells and signaling pathways in renal fibrosis and the interventional role of Chinese medicines.

Journal: Frontiers in pharmacology

Published: March 19, 2024

Icariin suppresses nephrotic syndrome by inhibiting pyroptosis and epithelial-to-mesenchymal transition.

Icariin suppresses nephrotic syndrome by inhibiting pyroptosis and epithelial-to-mesenchymal transition.

Journal: PloS one

Published: November 02, 2022

Renal tubular gen e biomarkers identification based on immune infiltrates in focal segmental glomerulosclerosis.

Renal tubular gen e biomarkers identification based on immune infiltrates in focal segmental glomerulosclerosis.

Journal: Renal failure

Published: June 17, 2022

The effectiveness of cyclosporine A for patients with steroid-resistant nephrotic syndrome: A protocol for systematic review and meta-analysis.

The effectiveness of cyclosporine A for patients with steroid-resistant nephrotic syndrome: A protocol for systematic review and meta-analysis.

Journal: Medicine

Published: November 18, 2021

Icariin synergizes therapeutic effect of dexamethasone on adriamycin-induced nephrotic syndrome.

Icariin synergizes therapeutic effect of dexamethasone on adriamycin-induced nephrotic syndrome.

Journal: European journal of medical research

Published: April 08, 2021

Calcineurin inhibitors in the treatment of primary focal segmental glomerulosclerosis: A protocol of systematic review and meta-analysis of randomized controlled trials.

Calcineurin inhibitors in the treatment of primary focal segmental glomerulosclerosis: A protocol of systematic review and meta-analysis of randomized controlled trials.

Journal: Medicine

Published: January 05, 2021

Quercetin suppresses glomerulosclerosis and TGF‑β signaling in a rat model.

Quercetin suppresses glomerulosclerosis and TGF‑β signaling in a rat model.

Journal: Molecular medicine reports

Published: December 01, 2017

Showing 1-11 of 11

Last Updated: 09/26/2026